Study S003371

A Single-Center, Single-Dose, Randomized, Open-Label, Single-Period, Parallel Bioequivalence Study of BGM0504 Injection in Overweight/Obese Participants

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07382908
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: RECRUITING
Enrollment: 144
Start: 2025-12-23
Primary completion: 2026-02-12
Lead sponsor: BrightGene Bio-Medical Technology Co., Ltd.
Conditions: Overweight/Obesity
Interventions: DRUG:BGM0504 Injection multi-dose pen; DRUG:BGM0504 Injection single-dose pen
Results posted: FALSE

Registered primary outcomes

Peak Plasma Concentration (Cmax) [0 to 672 hours]
Area under the plasma concentration versus time curve (AUC)0-t [0 to 672 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.